AMN Healthcare agrees to buy MSDR for $300M; expects Q4 2023 close

AMN HEALTHCARE SERVICES INC

Definitive agreement to acquire MSDR for $300 million cash; expected to close Q4 2023 subject to regulatory approvals.
MSDR had 2022 revenue of $104M and annualized YTD 2023 revenue of ~$155M.
Deal expected to be modestly accretive to adjusted EPS in first 12 months.
Annual cash tax savings of ~$2M for 15 years from DRW asset purchase structure.
MSDR CEO Chris Wang to remain as President of MSDR.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.